Electra Therapeutics
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $218M
Investors
- 13
About Electra Therapeutics
, aka Electra Therapeutics operates as a biotechnology company, focused on the development of novel drugs, intended to target SIRP (signal regulatory proteins), and thereby assist in the treatment of various diseases. In October 2025, Electra Therapeutics, Inc. Electra Therapeutics, Inc. engages in the development of a pipeline of antibody therapies, that targets specific SIRP (a class of cell surface receptors) proteins to eliminate the pathological immune cells, which causes various conditions including cancer and immunological illnesses. The company’s main product namely ELA026 (currently in Phase 1 clinical-stage), is a novel therapy developed for the treatment of a fatal hyperinflammatory condition called secondary hemophagocytic lymphohistiocytosis (sHLH).
Who invested in Electra Therapeutics
13 investors across 2 rounds
See all investors in Electra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Electra Therapeutics
Who invested in Electra Therapeutics?
Electra Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Electra Therapeutics raised?
Electra Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Electra Therapeutics last raise money?
Electra Therapeutics's most recent round on record is a Series C, in Oct 2025.
What does Electra Therapeutics do?
, aka Electra Therapeutics operates as a biotechnology company, focused on the development of novel drugs, intended to target SIRP (signal regulatory proteins), and thereby assist in the treatment of various diseases.
Where is Electra Therapeutics headquartered?
Electra Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Electra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Electra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Electra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.